Preoperative Glycemic Control on Total Joint Arthroplasty Patient Perceived Outcomes and Hospital Costs

Abstract Background The purpose of this study was to determine the influence of preoperative glycemic control in diabetic patients undergoing a primary total hip or knee arthroplasty. We wanted to study patient perceived outcomes in the medium term, the length of stay, hospital costs, and rate of sh...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of arthroplasty 2017-01, Vol.32 (1), p.6-10
Main Authors: Lavernia, Carlos J., MD, Heiner, Anneliese D., PhD, Villa, Jesus M., MD, Alcerro, Jose C., MD, Rossi, Mark D., PhD
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Arthroplasty, Replacement - adverse effects
Arthroplasty, Replacement - economics
complications
diabetes mellitus
Diabetes Mellitus, Type 2 - blood
Female
Glycated Hemoglobin A - analysis
HbA1c
Hospital Costs
Humans
Length of Stay
Male
Middle Aged
Orthopedics
outcomes
Patient Reported Outcome Measures
Preoperative Period
Quality of Life
Recovery of Function
total joint arthroplasty
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background The purpose of this study was to determine the influence of preoperative glycemic control in diabetic patients undergoing a primary total hip or knee arthroplasty. We wanted to study patient perceived outcomes in the medium term, the length of stay, hospital costs, and rate of short term postoperative complications. Methods One hundred and twenty consecutive primary TJAs performed in type 2 diabetic patients were stratified into two groups representing optimal and suboptimal preoperative glycemic control, based on serum levels of glycated hemoglobin (HbA1c ), and those groups compared. Results The mean follow-up time was 5.9 years (range 2.1 – 10.7 years). Both groups demonstrated improvement in all patient perceived outcome measures after TJA, with no significant difference detected in any change of a measure between the groups. No significant difference was detected in the length of stay, hospital costs, or rate of short term postoperative complications between the groups. Conclusion Preoperative diabetic control in type 2 diabetic patients undergoing TJA did not affect patient perceived outcomes in the medium term. Optimal versus suboptimal glycemic control in these patients also had no effect on the length of stay, hospital costs, or rate of short term postoperative complications.
ISSN:0883-5403
1532-8406
DOI:10.1016/j.arth.2016.07.002